methylene blue has been researched along with thromboxanes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clozel, M | 1 |
| Brezinski, ME; Lefer, AM; Smith, JA; Yanagisawa, A | 1 |
2 other study(ies) available for methylene blue and thromboxanes
| Article | Year |
|---|---|
Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Cilazapril; Endothelium, Vascular; Hypertension; Male; Methylene Blue; Nitric Oxide; Pyridazines; Rats; Rats, Inbred SHR; Serotonin; Thromboxanes; Vasoconstriction | 1991 |
Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Cats; Coronary Vessels; Cyclic GMP; Dose-Response Relationship, Drug; Endothelium; In Vitro Techniques; Male; Methylene Blue; Muscle, Smooth, Vascular; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Superoxides; Thromboxanes; Vasodilation | 1987 |